Comparison of the diagnostic values in rheumatoid arthritis: Anti-CCP antibodies and other serological tests

Basit Öğe Kaydı
dc.contributor.authorDogan, M.
dc.contributor.authorKucuksarac, S.
dc.contributor.authorTufekci, O.
dc.contributor.authorFeyzioglu, B.
dc.contributor.authorOzdemir, M.
dc.contributor.authorBaykan, M.
dc.contributor.authorBaysal, B.
dc.date.accessioned2024-02-23T14:45:55Z
dc.date.available2024-02-23T14:45:55Z
dc.date.issued2014
dc.departmentNEÜen_US
dc.description.abstractRheumatoid arthritis (RA) is an inflammatory autoimmune disease. Early diagnosis, early and aggressive treatment are the best means of avoiding joint destruction, organ damage and disability. This prospective study was carried out to determine the relationship between RA and laboratory tests used in the diagnosis of RA. 199 patients (20 males, 179 females; mean age: 50.6 years) that were suspected to be RA were included in the study. Anti-CCP, RF, ESR, and CRP tests were performed for all patients. The patients were divided two groups named RA and non-RA according to American College of Rheumatology criteria. Of the all patients, 96(48.2%) tested as positive for anti-CCP antibodies. Of the RA patients, 93 (68.9%) were positive for anti-CCP antibodies. The positivity of anti-CCP antibodies was 4.7% (3/64) for non-RA. Sensitivity, specificity, PPV, and NPV in diagnosis of RA for anti-CCP respectively were 0.69, 0.95, 0.97, and 0.59, and for high positive anti-CCP respectively were 0.55, 1.00, 1.00, and 0.52, and for RF respectively were 0.59, 0.92, 0.94, and 0.52, and for high positive RF respectively were 0.54, 0.98, 0.99, and 0.54, and for CRP respectively were 0.73, 0.78, 0.87, and 0.57, and for ESR respectively were 0.84, 0.30, 0.72, and 0.46. Sensitivity for the diagnosis of RA could be further increased by a combination of the anti-CCP and RF tests. There was a positive correlation between anti-CCP and RF positivity (Phi=0.59537), anti-CCP and RF high positivity (Phi=0.537364), ESR and CRP (Phi=0.426544). It is concluded that performing anti-CCP test in the diagnosis of RA could be beneficial since it has high specificity and positive predictive value. If this test was performed together with RF, it may be more beneficial.en_US
dc.identifier.endpage386en_US
dc.identifier.issn0970-938X
dc.identifier.issn0976-1683
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-84901790048en_US
dc.identifier.startpage381en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12452/17692
dc.identifier.volume25en_US
dc.identifier.wosWOS:000342566800019en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherAllied Acaden_US
dc.relation.ispartofBiomedical Research-Indiaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAnti-Cyclic Citrullinated Peptideen_US
dc.subjectRheumatoid Factoren_US
dc.subjectEsren_US
dc.subjectCrpen_US
dc.subjectRheumatoid Arthritisen_US
dc.titleComparison of the diagnostic values in rheumatoid arthritis: Anti-CCP antibodies and other serological testsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu